Lincoln Pharmaceuticals slips after Tanzania bans chloramphenicol sodium succinate injection

18 Jan 2016 Evaluate

Lincoln Pharmaceuticals is currently trading at Rs. 179.20, down by 44.70 points or 19.96% from its previous closing of Rs. 223.90 on the BSE.

The scrip opened at Rs. 221.00 and has touched a high and low of Rs. 223.00 and Rs. 179.20 respectively. So far 11,20,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 304.80 on 06-Jan-2016 and a 52 week low of Rs. 72.75 on 09-Mar-2015.

Last one week high and low of the scrip stood at Rs. 292.50 and Rs. 179.20 respectively. The current market cap of the company is Rs. 292.29 crore.

The promoters holding in the company stood at 36.11% while Institutions and Non-Institutions held 0.93% and 62.96% respectively.

Lincoln Pharmaceuticals’ highest selling chloramphenicol sodium succinate injection has been banned in Tanzania and the company's registration has also been cancelled there. Chloramphenicol Sodium Succinate Injection is an antibiotic used to treat serious bacterial infections.

Lincoln Pharmaceuticals is a company is based at Ahmedabad and engaged in Manufacturing and Export of Pharmaceuticals formulations under various Therapeutic product group, plant duly complied with WHO-GMP guidelines. The Company is exporting more than 45 countries along with Domestic market in more than 20 states in India.



Lincoln Pharma Share Price

599.90 18.85 (3.24%)
24-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.50
Dr. Reddys Lab 1201.45
Cipla 1551.30
Lupin 2104.90
Zydus Lifesciences 879.85
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...